(Q33780689)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Bridging the gap between cytotoxic and biologic therapy with metronomic topotecan and pazopanib in ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Anil K Sood

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

William M Merritt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Alpa M Nick

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Amy R Carroll

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Chunhua Lu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Melissa Dumble

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Nicholas Jennings

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Shuyun Zhang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Yvonne G Lin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Whitney A Spannuth

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Aparna A Kamat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Rebecca L Stone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Mian M K Shahzad

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Robert L Coleman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Rakesh Kumar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

6 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

Molecular Cancer Therapeutics

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

985-995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma

30 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC stu

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Oncologic imaging end-points for the assessment of therapy response

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Dicer, Drosha, and outcomes in patients with ovarian cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Functional significance of VEGFR-2 on ovarian cancer cells

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Pazopanib, a VEGF receptor tyrosine kinase inhibitor for cancer therapy

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Impact of vessel maturation on antiangiogenic therapy in ovarian cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Angiogenesis as a strategic target for ovarian cancer therapy

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Markers of angiogenesis in ovarian cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Antiangiogenic properties of metronomic chemotherapy in breast cancer.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Vascular endothelial growth factor (VEGF)-Receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

The anti-angiogenic basis of metronomic chemotherapy

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

The biology of VEGF and its receptors

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

The biology of vascular endothelial growth factor

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Tumor angiogenesis: therapeutic implications

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

The combination of the tyrosine kinase receptor inhibitor SU6668 with paclitaxel affects ascites formation and tumor spread in ovarian carcinoma xenografts growing orthotopically

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852465

Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20371710

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20371710

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1535-7163.MCT-09-0967

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

PubMed publication ID

20371710

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20371710%20AND%20SRC:MED&resulttype=core&format=json